Starpharma Holdings Ltd
SPL•Health Care•Biotechnology•Last updated: Dec 25
About
Starpharma Holdings Ltd is an Australian biotechnology company focused on the development of dendrimer products for pharmaceutical, life science, and other applications. The company operates through two main segments: VivaGel and DEP. VivaGel is a proprietary antiviral and antibacterial technology used in sexual health and other applications. The DEP segment involves the development of dendrimer-enhanced products, including drug delivery systems for oncology and other therapeutic areas.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- SPL
Related Shares
Investor Resources
Should you buy Starpharma Holdings Ltd right now?
While SPL looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now